Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 2, 2007, Pages 109-115

  Suarez Mier, G ^a   Giguere S ^a   Lee, E A ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DISPOSITION; DRUG HALF LIFE; FEMALE; FOAL; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BRONCHOALVEOLAR LAVAGE; CLARITHROMYCIN; ERYTHROMYCIN; FEMALE; HORSES; LUNG; MALE;

EID: 33847647486     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00833.x     Document Type: Article

References (35)

1. Baldwin, D.R., Wise, R., Andrews, J.M., Ashby, J.P. & Honeybourne, D. (1990) Azithromycin concentrations at the sites of pulmonary infection. European Respiratory Journal, 3, 886-890.
2. Baldwin, D.R., Honeybourne, D. & Wise, R. (1992) Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrobial Agents and Chemotherapy, 36, 1171-1175.
3. Bosnar, M., Kelneric, Z., Munic, V., Erakovic, V. & Parnham, M.J. (2005) Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrobial Agents and Chemotherapy, 49, 2372-2377.
4. Conte, J.E., Golden, J.A., Duncan, S., McKenna, E. & Zurlinden, E. (1995) Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrobial Agents and Chemotherapy, 39, 334-338.
5. Conte, J.E., Golden, J., Duncan, S., McKenna, E., Lin, E. & Zurlinden, E. (1996) Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrobial Agents and Chemotherapy, 40, 1617-1622.
6. Davis, J.L., Gardner, S.Y., Jones, S.L., Schwabenton, B.A. & Papich, M.G. (2002) Pharmacokinetics of azithromycin in foals after I.V. and oral dose and disposition into phagocytes. Journal of Veterinary Pharmacology and Therapeutics, 25, 99-104.
7. Drusano, G.L. (2005) Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics. Pharmacotherapy, 25, 150S-158S.
8. Fietta, A., Merlini C. & Gialdroni, G.G. (1997a) Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. Journal of Chemotherapy, 9, 17-22.
9. Fietta, A., Merlini, C. & Gialdroni, G.G. (1997b) Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. Journal of Chemotherapy, 9, 23-31.
10. Gibaldi, M. & Perrier, D. (1982) Noncompartmental analysis based on statistical moment theory. In Pharmacokinetics, 2nd edn, Eds Gibaldi, M. & Perrier, D., pp. 409-417. Marcel Dekker, New York.
11. Giguère, S., Jacks, S., Roberts, G.D., Hernandez, J., Long, M.T. & Ellis, C. (2004) Retrospective Comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. Journal of Veterinary Internal Medicine, 18, 568-573.
12. Girard, D., Finegan, S.M., Dunne, M.W. & Lame, M.E. (2005) Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models. The Journal of Antimicrobial Chemotherapy, 56, 365-371.
13. Hillidge, C.J. (1987) Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Veterinary Microbiology, 14, 337-342.
14. Hoffman, A.M., Viel, L., Muckle, C.A. & Tesarowski, D.B. (1991) Evaluation of a guarded bronchoscopic method for microbial sampling of the lower airways in foals. Canadian Journal of Veterinary Research, 55, 325-331.
15. Jacks, S., Giguère, S., Gronwall, P.R., Brown, M.P. & Merritt, K.A. (2001) Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. American Journal of Veterinary Research, 62, 1870-1875.
16. Jacks, S., Giguère, S., Gronwall R.R., Brown, M.P. & Merritt, K.A. (2002) Disposition of oral clarithromycin in foals. Journal of Veterinary Pharmacology and Therapeutics, 25, 359-362.
17. Jacks, S., Giguère, S. & Nguyen, A. (2003) In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin and 20 other antimicrobials. Antimicrobial Agents and Chemotherapy, 47, 1742-1745.
18. Labro, M.T. (1996) Intracellular bioactivity of macrolides. Clinical Microbiology and Infection, 2 (Suppl. 1), S24-S30.
19. Lakritz, J., Wilson, W.D. & Mihalyi, J.E. (1999) Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. American Journal of Veterinary Research, 60, 414-419.
20. Lakritz, J., Wilson, W.D., Marsh, A.E. & Mihalyi, J.E. (2000a) Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals. American Journal of Veterinary Research, 61, 1011-1015.
21. Lakritz, J., Wilson, W.D., Marsh, A.E. & Mihalyi, J.E. (2000b) Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. American Journal of Veterinary Research, 61, 914-919.
22. Maglio, D., Capitano, B., Banevicius, M.A., Geng, Q., Nightingale, C.H. & Nicolau, D.P. (2004) Differential efficacy of clarithromycin in lung versus thigh infection models. Chemotherapy, 50, 63-66.
23. Mandell, G.L. & Coleman, E. (2001) Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrobial Agents and Chemotherapy, 45, 1794-1798.
24. Morris, D.L., DeSouza, A., Jones, J.A. & Morgan, W.E. (1991) High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose. European Journal of Clinical Microbiology & Infectious Disese, 10, 859-861.
25. Patel, K.B., Xuan, D., Tessier, P.R., Russomanno, J.H., Quintiliani, R. & Nightingale, C.H. (1996) Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrobial Agents and Chemotherapy, 40, 2375-2379.
26. Prescott, J.F., Hoover, D.J. & Dohoo, I.R. (1983) Pharmacokinetics of erythromycin in foals and in adult horses. Journal of Veterinary Pharmacology and Therapeutics, 6, 67-73.
27. Rennard, S.I., Basset, G., Lecossier, D., O'Donnell, K.M., Pinkston, P., Martin, P.G. & Crystal, R.G. (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. Journal of Applied Physiology, 60, 532-538.
28. Retsema, J.A., Bergeron, J.M., Girard, D., Milisen, W.B. & Girard, A.E. (1993) Preferential concentration of azithromycin in an infected mouse thigh model. Journal of Antimicrobials and Chemotherapy, 31 (Suppl. E), 5-16.
29. Riedel, K.D., Wildfeuer, A., Laufen, H. & Zimmermann, T. (1992) Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples. Journal of Chromatography, 576, 358-362.
30. Rodvold, K.A., Gotfried, M.H., Danziger, L.H. & Servi, R.J. (1997) Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrobial Agents and Chemotherapy, 41, 1399-1402.
31. Stratton-Phelps, M., Wilson, W.D. & Gardner, I.A. (2000) Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 Cases (1986-1996). Journal of the American Veterinary Medical Assocciation, 217, 68-73.
32. Sweeney, C.R., Sweeney, R.W. & Divers, T.J. (1987) Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Veterinary Microbiology, 14, 329-336.
33. Sweeney, C.R., Rossier, Y., Ziemer, E.L. & Lindborg, S.R. (1994) Effect of prior lavage on bronchoalveolar lavage fluid cell population of lavaged and unlavaged lung segments in horses. American Journal of Veterinary Research, 55, 1501-1504.
34. Womble, A., Giguère, S., Murthy, Y.V.S.N., Cox, C. & Obare, E. (2006a) Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens. Journal of Veterinary Pharmacology and Therapeutics, 29, 561-568.
35. Womble, A.Y., Giguère, S., Lee, E.A. & Vickroy, T.W. (2006b) Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals. American Journal of Veterinary Research, 67, 1681-1686.